Narrow search
Showing 1 - 10 of 80,850
Cover Image
Deregulating Innovation Capital : The Effects of the JOBS Act on Biotech Startups
Lewis, Craig M. - 2020
IPOs since 2012. Reduced compliance costs encourage innovation capital formation as biotech IPO volume increases 200% and …
Persistent link: https://www.econbiz.de/10012829465
Cover Image
Where do social support and epistemic centrality come from? : the case of innovators in the French biotech industry
Stranger, Alvaro Pina; Varas, German; Gerard, Valentin - In: Administrative Sciences : open access journal 13 (2023) 8, pp. 1-29
The link between entrepreneur's network centrality and innovation performance has been broadly studied in knowledge … norms that are considered legitimated to carry out innovation in the biotech field. …
Persistent link: https://www.econbiz.de/10014370414
Cover Image
Erste Auswirkungen der Novellierung der Handwerksordnung von 2004
Müller, Klaus - 2006
Persistent link: https://www.econbiz.de/10012051482
Cover Image
Red tape reduction and firm entry : evidence from an Italian reform
Amici, Monica; Giacomelli, Silvia; Manaresi, Francesco; … - 2015
Persistent link: https://www.econbiz.de/10011821340
Cover Image
Red Tape Reduction and Firm Entry : Evidence from an Italian Reform
Amici, Monica - 2016
We estimate the effects of a simplification in the bureaucratic regulation for doing business on firm demographics in Italy, where a 2011 legislation reform required all municipalities to institute a one-stop shop for doing business. We use data for all Italian firms active in private...
Persistent link: https://www.econbiz.de/10012999587
Cover Image
Occupational deregulation, mixed embeddedness, and immigrant self-employment : The 2004 reform of the German crafts code as a quasi-experiment
Kuhnle, Jeremy - 2021
discontinuity design, this dissertation provides some first causal evidence of the effect of occupational deregulation on the self …
Persistent link: https://www.econbiz.de/10013419315
Cover Image
Erfolgsfaktoren für Biotechnologie-Regionen : sozialwissenschaftliche Begleitforschung zu den BioRegios ; Endbericht im Auftr. der Hans-Böckler-Stiftung und der Industriegewerkscha...
Eichener, Volker; Schaaf, Sabine; Schulte, Frank; … - 2000
Die biotechnologische Industrie zählt zu den Zukunftsbranchen mit hohen Wachstumspotentialen. Entsprechend hoch ist auch das Interesse politischer Akteure, die nationalen und regionalen Standortbedingungen für diese Zukunftsindustrien zu optimieren. In einer Situation, als Deutschland...
Persistent link: https://www.econbiz.de/10011378813
Cover Image
Profiting from technological capabilities : Technology commercialization strategy in a dynamic context
Wakeman, Simon - 2010
specialized commercialization capabilities. According to the predominant framework, if the innovation is protected by a strong … appropriabilty regime the optimal strategy is to license the innovation to an incumbent product firm. This paper argues by contrast … commercialize alone or to pursue a hybrid arrangement (called co-promotion) whereby it licenses the innovation but retains the …
Persistent link: https://www.econbiz.de/10010357556
Cover Image
The influence of personality traits of start-up entrepreneurs on the innovative market presence in the medical biotechnology and health care industry
Lányi, Beatrix - In: Marketing from information to decision 9 (2016), pp. 21-33
ways while making traditional attitudes outdated. Innovation, the process of bringing new products and services to market …, is one of the most important issue today. Innovation is responsible for raising the quality and lowering the prices of …
Persistent link: https://www.econbiz.de/10011657527
Cover Image
Science-based business : knowledge capital or entrepreneurial ability? ; theory and evidence from a survey of biotechnology start-ups
Braginskij, Sergej V.; Honjō, Yūji; Nagaoka, Sadao; … - 2010
We present a model of science-based entrepreneurship where ideas initially produced by researchers with high-level knowledge capital may be developed by high-ability entrepreneurs. With moderate investment costs, startups continuously managed by inventors-founders coexist in equilibrium with...
Persistent link: https://www.econbiz.de/10008664598